Molecular Biology Market Research Reports & Industry Analysis
In the field of scientific research, molecular biology enzymes, kits, and reagents play a fundamental role in understanding life at the molecular level. As technology and research practices shift, it's essential to stay informed about changes in the molecular biology market. MarketResearch.com offers a selection of authoritative reports to help you navigate this dynamic field.
Gauge the Pulse of the Molecular Biology Market
- In our collection of reports, you will find coverage of a variety of relevant markets including molecular biology simulation software, modeling techniques, laboratory equipment, and more.
- Use our research to gain in-depth analysis of market size, technological advancements, industry trends, and competitor strategies.
- Find objective market data and expert forecasts focusing on major world regions, types, and applications.
Take Advantage of Our Vast Research Database
Whether you are an experienced industry professional, a consultant, or executive, our molecular biology industry reports offer you dependable data to support your decision-making. These reports go beyond the basics — they provide a detailed roadmap to help you outperform competitors, seize emerging opportunities, and excel in an evolving landscape. Browse our collection today to access trusted research at the best price points available.
Molecular Biology Industry Research & Market Reports
-
South East Asia Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology, Gene Testing), End User - Forecast to 2031
... The Southeast Asia molecular diagnostics market is projected to reach USD 891.9 million by 2031 from an estimated USD 528.3 million in 2024, at a CAGR of 7.8% during the forecast period. Succeeding extensive secondary ... Read More
-
Global Exosomes Market - 2023-2030 (1)
... 200 nm, are secreted from cells to mediate signaling in the tumor necrosis factor (TNF)-induced mesenchymal stem cells (TME). Oncogenic EGFR can be shed from cells and interact with other TME cells. Exosomes from gastric ... Read More
-
Global Liquid Biopsy Market - 2024 - 2031
... to exhibit a CAGR of 15.4% during the forecast period 2024-2031. Liquid biopsy is a non-invasive medical test that detects and analyzes genetic and molecular alterations in a patient's blood or other bodily fluids. It ... Read More
-
Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034 Including: 1) By Type: Product; Services 2) By Cancer: Lung Cancer; Breast Cancer; Colon Cancer 3)By Sample: Blood; Urine; Saliva 4) By End User: Hospitals; Diagnostic Centers Covering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Guardant Health Inc.; Illumina Inc.; Exact Sciences Corporation
... biopsy for cancer diagnostics market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how ... Read More
-
Single Cell Analysis Market Size, Share & Trends By Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2029
... growth of this market can be attributed to the increasing focus on personalized medicine. The rising R&D investments pharmaceutical & biotechnology industries is propelling the growth of single-cell analysis. Additionally, factors such as growth in ... Read More
-
Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex), Test Type (Lab, PoC), Disease (STD, Flu, GI, HAI), Technology (PCR, NGS), End User (Diagnostic Labs, Hospitals) - Global Forecast to 2029
... advancements in molecular diagnostic technologies are the main driving force in the molecular infectious disease testing market. Advancements in PCR, next-generation sequencing, and other technologies enhance test accuracy, speed of completion, and efficiency, making them ... Read More
-
Oncology Molecular Diagnostics Market Report by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, and Others), Product (Instruments, Reagents, and Others), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization, Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), Mass Spectrometry, DNA and NGS Sequencing, Transcription Mediated Amplification (TMA), and Others), End-User (Hospitals and Clinics, Reference Laboratories, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of cancer, ongoing advancements in molecular diagnostic technologies, and increased adoption of precision medicine are primarily driving the market's growth. Oncology molecular diagnostics identify the presence of cancer cells by analyzing ... Read More
-
Europe Liquid Biopsy Market: Focus on End User and Country - Analysis and Forecast, 2024-2033
... 2024-2033. In Europe, liquid biopsy is a new non-invasive diagnostic technique that is transforming cancer detection and surveillance. This method has the potential to early detect cancer recurrence or evaluate treatment responses, and it provides ... Read More
-
Europe Hematologic Malignancies Testing Market: Focus on Product, Platform, Disease, End User, and Country - Analysis and Forecast, 2024-2033
... during the forecast period 2024-2033. Detecting and tracking blood cancers like leukemia, lymphoma, and myeloma is the primary focus of the Europe Hematologic Malignancies Testing Market. The market is expanding significantly due to the increasing ... Read More
-
Global Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
... Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute), for the historical period of 2020-2023, the estimates of 2024 ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Electrocompetent Cells, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Digital PCRs
... CAGR of 8.0% over the analysis period 2024-2030. Digital PCR Instruments, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$264.8 Million by the end of the ... Read More
-
Oligonucleotide Synthesis
... CAGR of 15.6% over the analysis period 2024-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Arbovirus Testing
... CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis ... Read More
-
Gel Documentation Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Gel Documentation Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$173.1 Million by the end ... Read More
-
Structural Biology and Molecular Modeling Techniques
... reach US$33.0 Billion by 2030, growing at a CAGR of 16.9% over the analysis period 2024-2030. SaaS & Standalone Modeling Tool, one of the segments analyzed in the report, is expected to record a 18.0% ... Read More
-
Real-time PCR (qPCR) and Digital PCR (dPCR)
... expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Quantitative Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR ... Read More
-
Molecular Breeding
... CAGR of 17.6% over the analysis period 2024-2030. Marker-Assisted Selection (MAS) Process, one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$11.7 Billion by the end of ... Read More
-
Protein Assays
... CAGR of 6.2% over the analysis period 2024-2030. Protein Assay Kits, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$938.4 Million by the end of the ... Read More
-
Transfection Technologies
... CAGR of 7.3% over the analysis period 2024-2030. Protein Production Application, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$694.1 Million by the end of the ... Read More
-
Transfection Reagents and Equipment
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the ... Read More
-
Live Cell Imaging
... at a CAGR of 7.5% over the analysis period 2024-2030. Live Cell Imaging Instruments, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.9 Billion by the ... Read More
-
Blotting Systems
... CAGR of 5.4% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$776.2 Million by the end ... Read More
-
Molecular Biology Enzymes and Kits & Reagents
... expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Molecular Biology Kits & Reagents, one of the segments analyzed in the report, is expected to record ... Read More
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Exosome Research Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by ... Read More
Research Assistance
